|
DE4337611A1
(de)
|
1993-11-04 |
1995-05-11 |
Boehringer Ingelheim Kg |
Neue Benzoylguanidine, ihre Herstellung und ihre Verwendung in Arzneimitteln
|
|
ES2293638T3
(es)
|
1994-03-25 |
2008-03-16 |
Isotechnika, Inc. |
Mejora de la eficacia de farmacos por deuteracion.
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
NZ511674A
(en)
*
|
1998-12-23 |
2003-11-28 |
Du Pont Pharm Co |
Nitrogen containing heterobicycles as factor Xa inhibitors
|
|
JP4166991B2
(ja)
|
2001-02-26 |
2008-10-15 |
田辺三菱製薬株式会社 |
ピリドピリミジンまたはナフチリジン誘導体
|
|
JP2004083587A
(ja)
|
2002-08-06 |
2004-03-18 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
ITFR20030005U1
(it)
|
2003-03-17 |
2003-06-16 |
C D R |
Sistema di protezione solare (frangisole f1)
|
|
JP2010208945A
(ja)
|
2007-06-01 |
2010-09-24 |
Mitsubishi Tanabe Pharma Corp |
複素環化合物
|
|
JP5063815B2
(ja)
|
2008-11-25 |
2012-10-31 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
抗腫瘍および抗神経変性剤としての二環式ピラゾールおよびイソオキサゾール誘導体
|
|
MX2012004846A
(es)
|
2009-10-29 |
2012-10-05 |
Genosco |
Inhibidores de cinasa.
|
|
RU2012131124A
(ru)
|
2009-12-23 |
2014-01-27 |
Элан Фармасьютикалз, Инк. |
Птеридиноны как ингибиторы polo-подобных киназ
|
|
WO2011115804A1
(en)
|
2010-03-17 |
2011-09-22 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
|
US9242981B2
(en)
*
|
2010-09-16 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
Fused pyrazole derivatives as novel ERK inhibitors
|
|
AU2011376721B2
(en)
|
2011-09-16 |
2017-06-08 |
Sanofi |
Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
|
|
EP2938610A2
(en)
|
2012-12-28 |
2015-11-04 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Inhibitors of the usp1/uaf1 deubiquitinase complex and uses thereof
|
|
CN104311555B
(zh)
|
2014-09-19 |
2016-04-20 |
广东东阳光药业有限公司 |
吡唑并哌啶酮类化合物及其组合物及用途
|
|
EP3632915A1
(en)
|
2014-11-27 |
2020-04-08 |
Genentech, Inc. |
4,5,6,7-tetrahydro-1 h-pyrazolo[4,3-c]pyridin-3-amine compounds as cbp and/or ep300 inhibitors
|
|
CN108473495B
(zh)
|
2015-11-20 |
2022-04-12 |
福马治疗有限公司 |
作为泛素-特异性蛋白酶1抑制剂的嘌呤酮
|
|
SG11201804901WA
(en)
|
2015-12-22 |
2018-07-30 |
SHY Therapeutics LLC |
Compounds for the treatment of cancer and inflammatory disease
|
|
JP7014736B2
(ja)
|
2016-05-24 |
2022-02-01 |
ジェネンテック， インコーポレイテッド |
がんの処置のためのピラゾロピリジン誘導体
|
|
EA201992780A1
(ru)
|
2017-06-21 |
2020-06-02 |
ШАЙ ТЕРАПЬЮТИКС ЭлЭлСи |
Соединения, которые взаимодействуют с суперсемейством ras, для лечения рака, воспалительных заболеваний, ras-опатий и фиброзного заболевания
|
|
US11413288B2
(en)
|
2017-11-01 |
2022-08-16 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancers
|
|
US11485736B2
(en)
*
|
2018-12-20 |
2022-11-01 |
KSQ Therapeutics, Inc. |
Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitors
|
|
US20220073525A1
(en)
*
|
2018-12-28 |
2022-03-10 |
Forma Therapeutics, Inc. |
Compositions for inhibiting ubiquitin specific protease 1
|
|
WO2021163530A1
(en)
*
|
2020-02-14 |
2021-08-19 |
KSQ Therapeutics, Inc. |
Therapeutic combinations comprising ubiquitin-specific-processing protease 1 (usp1) inhibitors and poly (adp-ribose) polymerase (parp) inhibitors
|
|
EP4161494A4
(en)
|
2020-06-02 |
2024-07-17 |
KSQ Therapeutics, Inc. |
NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS
|
|
KR20230098186A
(ko)
|
2020-10-30 |
2023-07-03 |
케이에스큐 세러퓨틱스 인코포레이티드 |
치환된 피라졸로피리미딘의 고체 상태 형태 및 이의 용도
|
|
WO2022174031A1
(en)
|
2021-02-12 |
2022-08-18 |
Relay Therapeutics, Inc. |
Cdk inhibitors and methods of use thereof
|
|
EP4291559A1
(en)
|
2021-02-15 |
2023-12-20 |
Tango Therapeutics, Inc. |
Pyrrolo[3,2-d]pyrimidine compounds and methods of use in the treatment of cancer
|
|
WO2022197892A1
(en)
|
2021-03-17 |
2022-09-22 |
Tango Therapeutics, Inc. |
Purine derivatives as anticancer agents
|
|
WO2022199652A1
(en)
|
2021-03-24 |
2022-09-29 |
Impact Therapeutics (Shanghai) , Inc |
Five-membered heteroaryl-pyrimidine compounds as usp1 inhibitors and the use thereof
|
|
CA3214040A1
(en)
|
2021-04-07 |
2022-10-13 |
Forma Therapeutics, Inc. |
Inhibiting ubiquitin-specific protease 1 (usp1)
|
|
CN117136189A
(zh)
|
2021-04-09 |
2023-11-28 |
先声再明医药有限公司 |
泛素特异性蛋白酶1（usp1）抑制剂
|
|
EP4430041A4
(en)
|
2021-11-12 |
2025-09-24 |
Insilico Medicine Ip Ltd |
SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) AND THEIR USES
|
|
IL312642A
(en)
|
2021-11-12 |
2024-07-01 |
Insilico Medicine Ip Ltd |
Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof
|
|
EP4430049A4
(en)
|
2021-11-12 |
2025-12-17 |
Insilico Medicine Ip Ltd |
Small molecule inhibitors of ubiquitin-specific protease 1 (USP1) and uses thereof
|
|
EP4605391A1
(en)
|
2022-10-21 |
2025-08-27 |
Exelixis, Inc. |
4,5,6,7-tetrahydro-1-pyrazolo[4,3-c]pyridine compounds and derivatives as usp1 inhibitors
|